Cai, L., Gu, J., Zheng, J., Zheng, M., Wang, G., Xi, L., . . . Okun, M. (2016). Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: Results from a phase 3, randomized, placebo‐controlled, double‐blind study. J Eur Acad Dermatol Venereol.
استشهاد بنمط شيكاغوCai, L., et al. "Efficacy and Safety of Adalimumab in Chinese Patients With Moderate‐to‐severe Plaque Psoriasis: Results From a Phase 3, Randomized, Placebo‐controlled, Double‐blind Study." J Eur Acad Dermatol Venereol 2016.
MLA استشهادCai, L., et al. "Efficacy and Safety of Adalimumab in Chinese Patients With Moderate‐to‐severe Plaque Psoriasis: Results From a Phase 3, Randomized, Placebo‐controlled, Double‐blind Study." J Eur Acad Dermatol Venereol 2016.